Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2006-08-25FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) from Eli Lilly and Company, expanding the labeling for the Zydis …
-
FDA approval · 2006-08-22FDA Approved: VALPROIC ACID — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for valproic acid from ANI Pharmaceuticals, indicating an approved change related to its product…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Omega-3 Fatty Acids in Bipolar Disorder [Phase 2]
A Phase 2 trial of omega-3 fatty acids for bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-04Clinical Trial Update: An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder [Phase 3]
This completed Phase 3 trial evaluated the effectiveness and safety of Depakote ER (divalproex sodium extended-release) for mania in bipolar…
-
CLINICAL_TRIALS trial_result · 2006-08-04Clinical Trial Update: An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents [Phase 3]
This update notes the completion of a Phase 3 outpatient trial evaluating the effectiveness and safety of Depakote ER for mania/bipolar diso…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-08-04Clinical Trial Update: Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness [Phase 4]
Phase 4 clinical trial evaluating Depakote monotherapy, olanzapine monotherapy, and their combination for maintenance bipolar disorder has b…
-
CLINICAL_TRIALS trial_result · 2006-07-25Clinical Trial Update: Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode [Phase 4]
This Phase 4 trial evaluated how long to continue olanzapine after remission from manic or mixed episodes in bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder [Phase 4]
Phase 4 trial comparing olanzapine to an active comparator for Bipolar I Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder [Phase 4]
Phase 4 trial completed evaluating a weight-gain agent for treating olanzapine-associated weight gain in patients with schizophrenia, schizo…
-
CLINICAL_TRIALS trial_result · 2006-07-13Clinical Trial Update: Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders [Phase 2]
This Phase 2 study evaluated repetitive transcranial magnetic stimulation (rTMS) for mood disorders and has completed. It included condition…
-
CLINICAL_TRIALS trial_result · 2006-06-09Clinical Trial Update: A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. [Phase 4]
A Phase 4 placebo-controlled trial of ropinirole for refractory bipolar depression is being conducted at Sheba Medical Center; the trial sta…
-
CLINICAL_TRIALS trial_result · 2006-05-25Clinical Trial Update: A Pilot Study of Psychodynamic Psychotherapy for Bipolar Disorder [NA]
This clinical trial update notes that a pilot study examining psychodynamic psychotherapy for Bipolar Disorder has completed.